VITALIX LAB
VITALIX LAB is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2024 annual accounts show equity of €5.99M and a net result of €-688k. Equity is shrinking by ~40.1% per year and would, assuming unchanged policy, indicatively turn negative around fiscal year 2026. Its solvency ranks better than 76% of 678 sector peers (fiscal year 2024). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €5.99M |
| Net result | €-688k |
| Staff (FTE) | 5.3 |
| Better than sector | 76% |
Mixed profile: strong on stability, weaker on profitability.
Computed on 4 of 5 axes. Not measured: health. An unmeasured axis is not a zero: no data was read for it.
This is a financial institution (bank, insurer or financial holding). Our bankruptcy model is trained on ordinary trading and manufacturing companies; a bank balance sheet falls outside that scope. We therefore show no bankruptcy probability rather than a misleading figure.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 77.8% | 44.9% | |
| Net result | €-688k | €48k | |
| Equity | €5.99M | €1.36M | |
| Gross operating margin | €228k | €42k | |
| Staff costs | €247k | €197k |
| Fiscal year | 2024 |
|---|---|
| Deposit | volledig |
| Revenue | n/a |
| EBITDA | n/a |
| Net profit | €-688k |
| Cash flow | n/a |
| Staff costs | €247k |
| Income taxes | €-318 |
| Dividends | - |
| Total assets | €7.70M |
| Equity | €5.99M |
| Debt | €1.69M |
| of which ≤ 1y | €604k |
| of which > 1y | €1.09M |
| Working capital | n/a |
| Employees (FTE) | 5.3 |
| 2024 | |
|---|---|
| Current ratio | n/a |
| Quick ratio | n/a |
| Working capital ratio | n/a |
| Solvency | 77.8% |
| Debt / equity | n/a |
| Long-term debt ratio | n/a |
| Interest coverage | n/a |
| Gross margin | n/a |
| Net margin | n/a |
| ROA | -8.9% |
| ROE | -11.5% |
| EBITDA margin | n/a |
| Days sales outstanding | n/a |
| Days payable outstanding | n/a |
| Inventory turnover | n/a |
| Days inventory (DSI) | n/a |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €7.70M |
| Fixed assets | 21/28 | €7.39M |
| Formation expenses | 20 | €9k |
| Intangible fixed assets | 21 | €130k |
| Financial fixed assets | 28 | €7.26M |
| Current assets | 29/58 | €300k |
| Amounts receivable within one year | 40/41 | €266k |
| Cash & bank | 54/58 | €21k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €7.70M |
| Equity | 10/15 | €5.99M |
| Contributions / capital | 10/11 | €20.40M |
| Accumulated profits (losses) | 14 | €-14.48M |
| Provisions & deferred taxes | 16 | €21k |
| Amounts payable | 17/49 | €1.69M |
| Amounts payable after one year | 17 | €1.09M |
| Amounts payable within one year | 42/48 | €604k |
| Trade debts payable within one year | 44 | €128k |
| Income statement | ||
| Gross operating margin | 9900 | €228k |
| Operating result | 9901 | €-61k |
| Financial income | 75 | €188k |
| Financial charges | 65 | €51k |
| Result before taxes | 9903 | €-720k |
| Income taxes | 67/77 | €-318 |
| Net result for the period | 9904 | €-688k |
| Result to be appropriated | 9905 | €-688k |
-
Current28-07-2021 → present
| NACE primary | Activiteiten van holdings(64210) |
| Legal form | Private limited company(610) |
| Incorporation | 29-07-2021 |
| Status | Active |
| Postal code | 1200 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21672C0070/00X000 | Brussels | 1.7 ha | 1 · 4,103 m² | 44.1 m · 4 fl. |
| 25782C0642/00C000 | Wallonia | 4,842 m² | 1 · 2,423 m² | 9.6 m · 2 fl. |
| 22006A0114/00P000 | Flanders | 520 m² | 1 · 325 m² | 14.8 m · 3 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
01-04-2026 Act object · General meeting · Officer resignation · Permanent representative
- Filing: 2026-03-25 · VITALIX LAB
- Publication: 2026-04-01 · VITALIX LAB
- Act object: Démission - Nomination représentant permanent · VITALIX LAB
- General meeting: 2025-12-11 · VITALIX LAB
- Officer resignation: date: 2025-10-21, role: représentant permanent · Christophe Picard
- Permanent representative: date: 2025-10-21, role: représentant permanent · Olivier Vander Cruysse
- Power of attorney: mandate: procéder à toute démarche liée à la présente assemblée, en ce compris la signature des documents de publication aux annexes du Moniteur belge · J. Jordens srl
- Power of attorney: mandate: procéder à toute démarche liée à la présente assemblée, en ce compris la signature des documents de publication aux annexes du Moniteur belge · Marion de Crombrugghe
Technical details
{
"facts": [
{
"type": "filing",
"quote": "D\u00E9pos\u00E9 / Re\u00E7u le 25 MARS 2026",
"value": "2026-03-25",
"object": null,
"subject": "e1"
},
{
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 01/04/2026",
"value": "2026-04-01",
"object": null,
"subject": "e1"
},
{
"type": "act_object",
"quote": "Objet de l\u0027acte: D\u00E9mission - Nomination repr\u00E9sentant permanent",
"value": "D\u00E9mission - Nomination repr\u00E9sentant permanent",
"object": null,
"subject": "e1"
},
{
"type": "general_meeting",
"quote": "Assembl\u00E9e G\u00E9n\u00E9rale extraordinaire du 11 d\u00E9cembre 2025",
"value": "2025-12-11",
"object": null,
"subject": "e1"
},
{
"type": "officer_resignation",
"quote": "L\u0027assembl\u00E9e acte la d\u00E9mission de Christophe Picard en tant que repr\u00E9sentant permanent de la SA INVEST FOR JOBS et nomme en remplacement Olivier Vander Cruysse.",
"value": {
"date": "2025-10-21",
"role": "repr\u00E9sentant permanent"
},
"object": "e1",
"subject": "e2"
},
{
"type": "permanent_representative",
"quote": "L\u0027assembl\u00E9e acte la d\u00E9mission de Christophe Picard en tant que repr\u00E9sentant permanent de la SA INVEST FOR JOBS et nomme en remplacement Olivier Vander Cruysse.",
"value": {
"date": "2025-10-21",
"role": "repr\u00E9sentant permanent"
},
"object": "e1",
"subject": "e4"
},
{
"type": "power_of_attorney",
"quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale mandate \u00E0 l\u0027unanimit\u00E9 des voix la soci\u00E9t\u00E9 J. Jordens srl / Marion de Crombrugghe aux fins de proc\u00E9der \u00E0 toute d\u00E9marche li\u00E9e \u00E0 la pr\u00E9sente assembl\u00E9e, en ce compris la signature des documents de publication aux annexes du Moniteur belge.",
"value": {
"mandate": "proc\u00E9der \u00E0 toute d\u00E9marche li\u00E9e \u00E0 la pr\u00E9sente assembl\u00E9e, en ce compris la signature des documents de publication aux annexes du Moniteur belge"
},
"object": "e1",
"subject": "e5"
},
{
"type": "power_of_attorney",
"quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale mandate \u00E0 l\u0027unanimit\u00E9 des voix la soci\u00E9t\u00E9 J. Jordens srl / Marion de Crombrugghe aux fins de proc\u00E9der \u00E0 toute d\u00E9marche li\u00E9e \u00E0 la pr\u00E9sente assembl\u00E9e, en ce compris la signature des documents de publication aux annexes du Moniteur belge.",
"value": {
"mandate": "proc\u00E9der \u00E0 toute d\u00E9marche li\u00E9e \u00E0 la pr\u00E9sente assembl\u00E9e, en ce compris la signature des documents de publication aux annexes du Moniteur belge"
},
"object": "e1",
"subject": "e6"
}
],
"act_meta": {
"model_id": 40,
"extractor": "open-capture-27b-v3",
"ocr_chars": 1416,
"truncated": false,
"needs_verify": false
},
"entities": [
{
"id": "e1",
"kbo": "0771.845.133",
"kind": "company",
"name": "VITALIX LAB",
"attrs": {
"seat": "Rue Saint-Lambert 135 - 1200 Woluwe-Saint-Lambert",
"legal_form": "SRL"
}
},
{
"id": "e2",
"kbo": null,
"kind": "person",
"name": "Christophe Picard",
"attrs": {}
},
{
"id": "e3",
"kbo": null,
"kind": "company",
"name": "SA INVEST FOR JOBS",
"attrs": {}
},
{
"id": "e4",
"kbo": null,
"kind": "person",
"name": "Olivier Vander Cruysse",
"attrs": {}
},
{
"id": "e5",
"kbo": null,
"kind": "company",
"name": "J. Jordens srl",
"attrs": {}
},
{
"id": "e6",
"kbo": null,
"kind": "person",
"name": "Marion de Crombrugghe",
"attrs": {}
}
]
}24-06-2025 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": true,
"seat_change": false,
"object_change": true,
"effective_date": "2025-06-17",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0771.845.133",
"name_full": "KAZIDOMI GROUP",
"legal_form": "SRL"
},
"signature_regime": null,
"special_mandates": [
{
"quote": "A \u00E9t\u00E9 d\u00E9sign\u00E9e comme mandataire particulier, afin de remplir les formali-t\u00E9s n\u00E9cessaires aupr\u00E8s de la banque carrefour des entreprises et aupr\u00E8s de toute administration comp\u00E9tente : La soci\u00E9t\u00E9 ACOFISCO, \u00E0 1200 Bruxelles, boulevard Brand Whitlock 24A. A ces fins, le mandataire pourra, au nom de la soci\u00E9t\u00E9, faire toutes d\u00E9clarations, passer et signer tous actes, pi\u00E8ces et documents, substituer et, en g\u00E9n\u00E9ral, faire tout ce qui est n\u00E9cessaire dans l\u0027acception la plus large du terme.",
"holder_kbo": null,
"holder_name": "ACOFISCO",
"scope_categories": [
"KBO",
"filing",
"administrative_formalities"
],
"with_substitution": true
}
],
"governance_change": {
"admin_delegated_added": []
}
}09-08-2024 Capital increase of €350,000 to €20,403,046.15
- €20.053.046,15 → €20.403.046,15
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 350000.0,
"currency": "EUR",
"after_eur": 20403046.15,
"delta_eur": 350000.0,
"before_eur": 20053046.15,
"amount_type": "kapitaal_effectief",
"effective_date": "2024-07-31",
"evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide d\u2019augmenter les capitaux propres par apport en esp\u00E8ces \u00E0 concurrence de trois cent cinquante mille euros (350.000,00 \u20AC) pour les porter de vingt millions cinquante-trois mille quarante-six euros quinze cents (20.053.046,15 \u20AC), \u00E0 vingt millions quatre cent drie mille quarante-zes euros quinze cents (20.403.046,15 \u20AC)",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0771.845.133",
"name_full": "KAZIDOMI GROUP",
"legal_form": "SRL"
}
}10-11-2023 Capital increase of €1,373,934.25 to €20,053,046.15
- €18.679.111,90 → €20.053.046,15
- 2 kapitaalbewegingen in deze akte
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 907249.9,
"currency": "EUR",
"after_eur": 18679111.9,
"delta_eur": 907249.9,
"before_eur": 17771862.0,
"amount_type": "kapitaal_effectief",
"effective_date": "2023-11-06",
"evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide d\u2019augmenter les capitaux propres par apport en esp\u00E8ces \u00E0 concurrence de neuf cent sept mille deux cent quarante-neuf euros nonante centimes (907.249,90 \u20AC) pour les porter de dix-sept millions sept cent septante et un mille huit cent soixante-deux euros (17.771.862,00 \u20AC) \u00E0 dix-huit millions six cent septante-neuf mille cent onze euros nonante cents (18.679.111,90 \u20AC)",
"contribution_type": "cash"
},
{
"kind": "capital_increase",
"amount": 1373934.25,
"currency": "EUR",
"after_eur": 20053046.15,
"delta_eur": 1373934.25,
"before_eur": 18679111.9,
"amount_type": "kapitaal_effectief",
"effective_date": "2023-11-06",
"evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide d\u2019augmenter les capitaux propres de la soci\u00E9t\u00E9, en nature... \u00E0 concurrence d\u2019un million trois cent septante-trois mille neuf cent trente-quatre euros vingt-cinq centimes (1.373.934,25 \u20AC) pour les porter de dix-huit millions six cent septante-neuf mille cent onze euros nonante cents (18.679.111,90 \u20AC) \u00E0 vingt millions cinquante-trois mille quarante-six euros quinze cents (20.053.046,15 \u20AC)",
"contribution_type": "in_kind"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0771.845.133",
"name_full": "KAZIDOMI GROUP",
"legal_form": "SRL"
}
}01-09-2023 Change in the board of directors
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0771.845.133",
"name_full": "KAZIDOMI GROUP",
"legal_form": "SRL"
}
}30-03-2023 Change in the board of directors
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0771.845.133",
"name_full": "KAZIDOMI GROUP",
"legal_form": "SRL"
}
}11-02-2022 Camille Depuydt appointed as director
- Camille Depuydt, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Camille Depuydt",
"address": null,
"birth_date": null
},
"effective_date": "2021-07-28",
"evidence_quote": "Les actionnaires d\u00E9cident de nommer en tant qu\u0027administrateur, et ce avec effet au 28/07/2021, Madame Camille Depuydt, n\u00E9e le 07/09/1988, domicili\u00E9e \u00E0 Kruishofstraat 22, 2020 Anvers."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0771.845.133",
"name_full": "KAZIDOMI GROUP",
"legal_form": "SRL"
}
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | VITALIX LAB |